Suzuken Co., Ltd. operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Suzuken Co., Ltd. with three other
companies in this sector in Japan:
Alfresa Holdings Corporation
sales of 2.64 trillion Japanese Yen [US$24.27 billion]
of which 88%
was Wholesale Business of Pharmaceuticals fo),
Toho Holdings Company Limited
(1.22 trillion Japanese Yen [US$11.23 billion]
of which 92%
was Pharmaceutical Wholesale Business), and
Medipal Holdings Corporation
(3.18 trillion Japanese Yen [US$29.24 billion]
of which 66%
was Pharmaceuticals And Food Precessing Whol).
During the year ended March of 2019, sales at
Suzuken Co., Ltd. were ¥2.13 trillion (US$19.60 billion).
a very small
increase of 0.4%
versus 2018, when the company's sales were ¥2.12 trillion.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Suzuken Co., Ltd. had sales
of ¥1.99 trillion.
Sales of Medical-Related Business Services, Etc. saw an increase
that was more than double the company's growth rate: sales were up
1.6% in 2019, from
¥28.24 billion to ¥28.68 billion.
Suzuken Co., Ltd. also saw significant increases in sales in
Pharmaceutical Wholesale Business (up 0.7% to ¥1.99 trillion)
Not all segments of Suzuken Co., Ltd. experienced an increase in sales in 2019:
sales of Pharmacy Business Insurance fell 4.9% to ¥94.64 billion.
(However, this segment's sales were only a very small portion of the company's overall sales).
Suzuken Co., Ltd. also experienced decreases in sales in
Pharmaceutical Manufacturing Business (down 3.4% to ¥15.83 billion)